Mesa Laboratories Inc (MLAB)
Cash ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 30,956 | 24,337 | 28,472 | 28,214 | 28,224 | 35,617 | 32,376 | 32,910 | 26,101 | 32,377 | 43,747 | 49,346 | 51,706 | 278,294 | 275,710 | 263,865 | 253,731 | 241,924 | 230,951 | 81,380 |
Short-term investments | US$ in thousands | — | — | 1,514 | — | 2,143 | 1,563 | 1,387 | — | 1,702 | 2,787 | — | — | — | — | — | — | — | — | — | — |
Total current liabilities | US$ in thousands | 155,878 | 153,230 | 54,865 | 44,312 | 44,183 | 39,816 | 39,126 | 43,359 | 41,617 | 41,506 | 44,127 | 48,055 | 46,775 | 28,690 | 33,448 | 32,583 | 27,750 | 19,533 | 20,475 | 26,008 |
Cash ratio | 0.20 | 0.16 | 0.55 | 0.64 | 0.69 | 0.93 | 0.86 | 0.76 | 0.67 | 0.85 | 0.99 | 1.03 | 1.11 | 9.70 | 8.24 | 8.10 | 9.14 | 12.39 | 11.28 | 3.13 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($30,956K
+ $—K)
÷ $155,878K
= 0.20
The cash ratio of Mesa Laboratories Inc has been fluctuating over the period analyzed. The cash ratio measures the company's ability to cover its short-term liabilities with its cash and cash equivalents.
Between March 31, 2020, and September 30, 2021, the cash ratio consistently increased, indicating an improving ability to cover short-term obligations with cash on hand. However, by December 31, 2021, the ratio dropped significantly to 1.11, suggesting a potential decrease in liquidity.
From March 31, 2022, to June 30, 2024, the cash ratio continued to decline, reaching as low as 0.16 by September 30, 2024. This downward trend may raise concerns about the company's liquidity position and its ability to meet short-term liabilities solely through its cash reserves.
Overall, a decreasing cash ratio implies a decreasing ability to cover short-term obligations with cash on hand, which could potentially indicate liquidity challenges for Mesa Laboratories Inc if the trend continues.
Peer comparison
Dec 31, 2024